Nuveen Asset Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.64M | Sell |
359,572
-162,291
| -31% | -$1.19M | ﹤0.01% | 2269 |
|
|
2024
Q3 | $3.91M | Buy |
521,863
+305,653
| +141% | +$2.29M | ﹤0.01% | 2104 |
|
|
2024
Q2 | $1.92M | Buy |
216,210
+7,910
| +4% | +$70.4K | ﹤0.01% | 2414 |
|
|
2024
Q1 | $2.11M | Hold |
208,300
| – | – | ﹤0.01% | 2375 |
|
|
2023
Q4 | $2.1M | Buy |
208,300
+2,942
| +1% | +$29.6K | ﹤0.01% | 2392 |
|
|
2023
Q3 | $1.92M | Sell |
205,358
-1,378
| -0.7% | -$12.9K | ﹤0.01% | 2307 |
|
|
2023
Q2 | $5.07M | Sell |
206,736
-101,187
| -33% | -$2.48M | ﹤0.01% | 1896 |
|
|
2023
Q1 | $7.17M | Sell |
307,923
-185,799
| -38% | -$4.32M | ﹤0.01% | 1683 |
|
|
2022
Q4 | $12.5M | Sell |
493,722
-72,659
| -13% | -$1.84M | ﹤0.01% | 1347 |
|
|
2022
Q3 | $10.9M | Sell |
566,381
-99,846
| -15% | -$1.92M | ﹤0.01% | 1421 |
|
|
2022
Q2 | $17M | Sell |
666,227
-124,437
| -16% | -$3.17M | 0.01% | 1160 |
|
|
2022
Q1 | $20M | Buy |
790,664
+170,599
| +28% | +$4.32M | 0.01% | 1196 |
|
|
2021
Q4 | $26M | Buy |
620,065
+285,300
| +85% | +$11.9M | 0.01% | 1066 |
|
|
2021
Q3 | $14.6M | Buy |
334,765
+98,520
| +42% | +$4.29M | ﹤0.01% | 1500 |
|
|
2021
Q2 | $11.2M | Buy |
236,245
+5,118
| +2% | +$242K | ﹤0.01% | 1802 |
|
|
2021
Q1 | $11.9M | Sell |
231,127
-2,814
| -1% | -$144K | ﹤0.01% | 1691 |
|
|
2020
Q4 | $6.27M | Sell |
233,941
-95,707
| -29% | -$2.56M | ﹤0.01% | 1951 |
|
|
2020
Q3 | $11.3M | Buy |
329,648
+102,971
| +45% | +$3.53M | ﹤0.01% | 1445 |
|
|
2020
Q2 | $9.29M | Buy |
226,677
+189,973
| +518% | +$7.78M | ﹤0.01% | 1524 |
|
|
2020
Q1 | $1.26M | Buy |
36,704
+25,364
| +224% | +$869K | ﹤0.01% | 2409 |
|
|
2019
Q4 | $143K | Buy |
+11,340
| New | +$143K | ﹤0.01% | 3101 |
|